期刊文献+

药源性帕金森综合征的临床分析 被引量:7

Clinical analysis of drug-induced parkinsonism
下载PDF
导出
摘要 目的:探讨药源性帕金森综合征(DIP)的临床特点,与原发性帕金森病的鉴别诊断及治疗体会。方法:对84例临床诊断为药源性帕金森综合征患者的资料进行回顾性分析。结果:84例患者均有明确的用药史,用药14d~6年后出现帕金森综合征表现,67.86%在3个月内出现DIP的表现;均双侧肢体对称起病,11例患者以一侧症状较重;临床表现以运动迟缓、肌强直为主;本组患者25%同时出现迟发性运动障碍,10.71%同时合并静坐不能,7.14%同时合并肌张力障碍。异丙嗪、硫必利等药物对症治疗有效。结论:药源性帕金森综合征的临床特点与原发性帕金森病相似,仍有一些特征性的表现可与其相鉴别,两者的治疗不同,药源性帕金森综合征最好的治疗就是预防,给予适当的对症治疗,可改善患者的症状。 Objective: To investigate the clinical features, differential diagnosis and treatment of druginduced parkinsonism (DIP). Methods: A retrospective analysis of 84 cases with clinically diagnosed DIP was conducted. Results: 84 patients had definitive histories of using drugs. DIP appeared from 14 days to 6 years after taking medicines,67.86% patients appeared within 3 months.The main symptoms of DIP were bradykinesia and rigidity.Onset was bilateralis, symmetric signs, but the symptoms of 11 cases were asymmetric. Simultaneously,25% patients appeared tardive dyskinesia, 10.71% exhibited akathisia, 7.14% appeared dystonia. Some medicines,such as proazamine and Tiapride Hydrchloride were effective to control symptoms. Conclusion: DIP is often clinically similar with primary parkinsonism. However, some clinical characteristics are beneficial to differential diagnosis. The treatment of DIP is differen from primary parkinsonism, the best method is prevention, symptomatic therapy can alleviate clinical symptoms of patients.
作者 刘红 张本恕
出处 《天津医科大学学报》 2009年第1期57-59,69,共4页 Journal of Tianjin Medical University
关键词 药源性帕金森综合征 临床特点 鉴别诊断 治疗 Drug-induced parkinsonism Clinical features Differential diagnosis Drug therapy
  • 相关文献

参考文献12

  • 1American Psychiatric Association. Diagnostic and statiatical manual disorders [M]. 4 th ed. Washington,DC:American Psychiatric Assoeiation, 1994:303-312,693-703.
  • 2Hirose G.Drug induced parkinsonism[J]. J Neurol,2006,253( Suppl 3): S23.
  • 3Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly[J].Mov Disord, 2008, 23(3):401.
  • 4Van Gerpen JA.Drug-induced parkinsonism [J].Neurologist, 2002,8 (6):365.
  • 5Sethi KD, Zamrini EY. Asymmetry in clinical features of drug induced parkinsonism[J]. J Neuropsyehiatry Clin Neurosci,1990, 2(1):64.
  • 6Hassin-Baer S,Sirota P,Korczyn AD, et al.Clinical characteristics of neuroleptic-indueed parkinsonism [J]. J Neural Transm,2001, 108 (11):1299.
  • 7Samaha AN,Seeman P,Stewart J, et al. "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time[J]. J Neurosci, 2007, 27(11):2984.
  • 8Miller R.Dose-response relationships for the antipsychotic effects and parkinsonian side-effects of typical neuroleptic drugs: practical and theoretical implications [J].Prog Neuropsychopharmacol Biol Psychiatry, 1997,21 (7): 1059.
  • 9World Health Organization,Heads of centres collaborating in WHO co-ordinated studies on biological aspects of mental illness. Prophylactic use of anticholinergies in patients on long-term neuroleptic treatment:a consensus statement[J]. BrJ Psychiatry, 1990,156:412.
  • 10Rodnitzky RL.Drug-induced movement disorders [J].Clin Neurophar macol, 2002, 25(3): 146.

同被引文献44

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部